GRO-α/CXCR2 system and ADAM17 correlated expression in Sjögren's syndrome

Inflammation

Volumn 36, Issue 3, 2013, Pages 759-766

  Lisi, Sabrina ^a   Sisto, Margherita ^a   Lofrumento, Dario Domenico ^b   D'Amore, Massimo ^a   De Lucro, Raffaella ^a   Ribatti, Domenico ^a  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^b UNIVERSITY OF SALENTO   (Italy)

Author keywords

ADAM 17; CXCR2; GRO ; sj gren's syndrome; TAPI 1

Indexed keywords

ADAM PROTEIN; ALPHA CHEMOKINE; CHEMOKINE RECEPTOR CXCR2; GROWTH RELATED ONCOGENE ALPHA; METALLOPROTEINASE INHIBITOR; PROTEIN ADAM17; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; PROTEIN EXPRESSION; PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SALIVARY GLAND; SJOEGREN SYNDROME; WESTERN BLOTTING;

ADAM PROTEINS; CELLS, CULTURED; CHEMOKINE CXCL1; DIPEPTIDES; ENZYME ACTIVATION; EPITHELIAL CELLS; GENE EXPRESSION; HUMANS; HYDROXAMIC ACIDS; INFLAMMATION; METALLOENDOPEPTIDASES; RECEPTORS, INTERLEUKIN-8B; SALIVARY GLANDS; SJOGREN'S SYNDROME;

EID: 84877753465     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-013-9602-6     Document Type: Article

References (27)

1. Gallo, A., C. Baldini, L. Teos, M. Mosca, S. Bombardieri, and I. Alevizos. 2012. Emerging trends in Sjögren's syndrome: basic and translational research. Clinical and Experimental Rheumatology 30: 779-784.
2. Mostafa, S., V. Seamon, and A.M. Azzarolo. 2012. Influence of sex hormones and genetic predisposition in Sjögren's syndrome: a new clue to the immunopathogenesis of dry eye disease. Experimental Eye Research 96: 88-97.
3. Tzioufas, A.G., and M. Voulgarelis. 2007. Update on Sjögren's syndrome autoimmune epithelitis: from classification to increased neoplasias. Best Practice & Research. Clinical Rheumatology 21: 989-1010.
4. Sisto, M., S. Lisi, D.D. Lofrumento, M. D'Amore, M.A. Frassanito, and D. Ribatti. 2012. Sjögren's syndrome pathological neovascularization is regulated by VEGF-A-stimulated TACE-dependent crosstalk between VEGFR2 and NF-κB. Genes and Immunity 13: 411-420.
5. Lisi, S., M. Sisto, D.D. Lofrumento, and M. D'Amore. 2012. Sjögren's syndrome autoantibodies provoke changes in gene expression profiles of inflammatory cytokines triggering a pathway involving TACE/NF-κB. Laboratory Investigation 92: 615-624.
6. Sisto, M., S. Lisi, D.D. Lofrumento, G. Ingravallo, V. Mitolo, and M. D'Amore. 2012. Expression of pro-inflammatory TACE-TNF-α-amphiregulin axis in Sjögren's syndrome salivary glands. Histochemistry and Cell Biology 134: 345-353.
7. Lisi, S., M. Sisto, D.D. Lofrumento, L. Cucci, M.A. Frassanito, V. Mitolo, and M. D'Amore. 2010. Pro-inflammatory role of anti-Ro/SSA autoantibodies through the activation of Furin-TACE-amphiregulin axis. Journal of Autoimmunity 35: 160-170.
8. Sisto, M., S. Lisi, D.D. Lofrumento, S. Caprio, V. Mitolo, and M. D'Amore. 2010. TNF blocker drugs modulate human TNF-α-converting enzyme pro-domain shedding induced by autoantibodies. Immunobiology 215: 874-883.
9. Sisto, M., S. Lisi, D.D. Lofrumento, M.A. Frassanito, L. Cucci, S. D'Amore, V. Mitolo, and M. D'Amore. 2009. Induction of TNF-alpha-converting enzyme-ectodomain shedding by pathogenic autoantibodies. International Immunology 21: 1341-1349.
10. Sisto, M., S. Lisi, D.D. Lofrumento, M. D'Amore, and D. Ribatti. 2012. Neuropilin-1 is upregulated in Sjögren's syndrome and contributes to pathological neovascularization. Histochemestry of Cell Biology 137: 669-677.
11. Sorokin, L. 2010. The impact of the extracellular matrix on inflammation. Nature Review Immunology 10: 712-723.
12. Klein, T., and R. Bischoff. 2011. Physiology and pathophysiology of matrix metalloproteases. Amino Acids 41: 271-290.
13. Garton, K.J., P.J. Gough, and E.W. Raines. 2006. Emerging roles for ectodomain shedding in the regulation of inflammatory responses. Journal of Leukocyte Biology 79: 1105-1106.
14. Black, R.A., C.T. Rauch, C.J. Kozlosky, J.J. Peschon, J.L. Slack, M.F. Wolfson, B.J. Castner, K.L. Stocking, P. Reddy, S. Srinivasan, N. Nelson, N. Boiani, K.A. Schooley, M. Gerhart, R. Davis, J.N. Fitzner, R.S. Johnson, R.J. Paxton, C.J. March, and D.P. Cerretti. 1997. A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells. Nature 385: 729-732.
15. Reutershan, J. 2006. CXCR2 - the receptor to hit? Drug News Perspective 19: 615-623.
16. Lisi, S., M. Sisto, D.D. Lofrumento, and M. D'Amore. 2012. Altered IκBα expression promotes NF-κB activation in monocytes from primary Sjögren's syndrome patients. Pathology 44: 557-561.
17. Khandaker, M.H., G. Mitchell, L. Xu, J.D. Andrews, R. Singh, H. Leung, J. Madrenas, S.S. Ferguson, R.D. Feldman, and D.J. Kelvin. 1999. Metalloproteinases are involved in lipopolysaccharide- and tumor necrosis factor-alpha-mediated regulation of CXCR1 and CXCR2 chemokine receptor expression. Blood 93: 2173-2185.
18. Saftig, P., and K. Reis. 2011. The «a disintegrin and metalloproteases» ADAM10 and ADAM17: novel drug targets with therapeutic potential? European Journal of Cell Biology 90: 527-535.
19. Vitali, C. 2003. Classification criteria for Sjögren's syndrome. Annals of the Rheumatic Diseases 2003(62): 94-95.
20. Sens, D.A., D.S. Hintz, M.T. Rudisill, M.A. Sens, and S.S. Spicer. 1985. Explant culture of human submandibular gland epithelial cells: evidence for ductal origin. Laboratory Investigation 52: 559-567.
21. Kapsogeorgou, E.K., H.M. Moutsopoulos, and M.N. Manoussakis. 2001. Functional expression of a costimulatory B7.2 (CD86) protein on human salivary gland epithelial cells that interacts with the CD28 receptor, but has reduced binding to CTLA4. Journal of Immunology 166: 3107-3113.
22. Von Andrian, U.H., and C.R. Mackay. 2000. T-cell function and migration. Two sides of the same coin. The New England Journal of Medicine 343: 1020-1034.
23. Le, Y.Y., Zhou, P.I., and J.M. Wang. 2004. Chemokines and chemokine receptors: their manifold roles in homeostasis and disease. Cellular & Molecular Immunology 1: 95-104.
24. Parks, W.C., C.L. Wilson, and Y.S. Lopez-Boado. 2004. Matrix metalloproteinases as modulators of inflammation and innate immunity. Nature Review Immunology 4: 617-629.
25. Filipovic, R., I. Jakovcevski, and N. Zecevic. 2003. GRO-alpha and CXCR2 in the human fetal brain and multiple sclerosis lesions. Developmental Neuroscience 25: 279-290.
26. Breland, U.M., B. Halvorsen, J. Hol, E. Øie, G. Paulsson-Berne, A. Yndestad, C. Smith, K. Otterdal, U. Hedin, T. Waehre, W.J. Sandberg, S.S. Frøland, G. Haraldsen, L. Gullestad, J.K. Damås, G.K. Hansson, and P. Aukrust. 2008. A potential role of the CXC chemokine GROalpha in atherosclerosis and plaque destabilization: downregulatory effects of statins. Arteriosclerosis, Thrombosis, and Vascular Biology 28: 1005-1011.
27. Dogan, R.N., and W.J. Karpus. 2004. Chemokines and chemokine receptors in autoimmune encephalomyelitis as a model for central nervous system inflammatory disease regulation. Frontiers in Bioscience 9: 1500-1505.